DGAP-Adhoc: GEA Group Aktiengesellschaft: Preliminary

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Oct 20, 2016 at 2:00 AM

DGAP-Adhoc: GEA Group Aktiengesellschaft: Preliminary Q3-figures, adjustment of Guidance for 2016

GEA Group Aktiengesellschaft / Key word(s): Quarter Results/Change in Forecast 19.10.2016 23:52 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad-hoc notification pursuant to sec. 15 WpHG Preliminary Q3-figures, adjustment of Guidance for 2016 Düsseldorf, October 19, 2016 - Based on preliminary figures for September 2016, GEA expects for Q3 2016 sales around EUR 1,100 million (last year EUR 1,107 million, -1.8% organic change - i.e. adjusted for currency and acquisition effects - against Q3 2015), order intake around EUR 1,084 million (last year EUR 1,068 million, 0.3% organic change against Q3 2015) and operating EBITDA* around EUR 113 million (last year EUR 144 million). Influencing factors for sales - Business Area Solutions: Slower execution mainly of dairy processing projects - in large parts customer induced - and decline in cooling solutions for the oil and gas industry leading to an approx. 4.5% organic decline - Business Area Equipment: Limited overall growth in light of an organic decline of approx. 8% in the dairy farming business Influencing factors for order intake Only slight organic growth due to delays in the placement of larger dairy processing orders which were expected for Q3 2016, as well as a continuing investment-restraint in the dairy farming and oil and gas industries. Influencing factors EBITDA - Business Area Solutions: Cost overruns in a couple of large projects including additional provisions for remaining risks from these; adverse operating leverage effect from approx. 4.5% organic sales decline of the entire business area in Q3 2016 compared to previous year - Business Area Equipment: Adverse operating leverage effect from 8% organic sales decline in the dairy farming business during Q3 2016 compared to previous year The figures for September revealed that adverse impacts for the group had accrued to such an extent that further potentials to fully mitigate these impacts until year's end by countermeasures such as additional saving initiatives seemed exhausted. While all other businesses are on track, they cannot mitigate the above mentioned adverse effects any more. As a consequence, GEA adjusts its guidance for the financial year 2016 with assumptions unchanged as follows: - Moderate sales decline against prior year (previously: moderate increase) - An operating EBITDA* of around EUR 570 million including approx. EUR 10 million from the acquisition Imaforni (previously: guided range between EUR 645 million and EUR 715 million without Imaforni) - Operating cash flow driver margin** around 10% (previously: 10.0-11.0%) The mid-term financial targets given at the occasion of the Capital Markets Day at the beginning of October 2016 are confirmed in all aspects (see CMD 2016 presentation p. 98; accessible at www.gea.com). GEA's Q3 results will be published on 28 October 2016. * operating EBITDA is defined in GEA's half-yearly financial report 2016, p. 42 ** operating cash flow driver margin is defined in GEA's half-yearly financial report 2016, p. 3, FN 2 GEA's half-yearly financial report 2016 is accessible at www.gea.com. Contact: GEA Group Aktiengesellschaft Phone +49 (0)211 9136 1492 Fax +49 (0)211 9136 31087 www.gea.com 19.10.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: GEA Group Aktiengesellschaft Peter-Müller-Straße 12 40468 Düsseldorf Germany Phone: +49 (0)211 9136-0 Fax: +49 (0)211 9136-31087 E-mail: ir@gea.com Internet: www.gea.com ISIN: DE0006602006 WKN: 660200 Indices: MDAX Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Munich; Regulated Unofficial Market in Hanover, Stuttgart, Tradegate Exchange End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Off-Broadway Play 'DUST' Raises Autism Support Funds

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

NatGold Pulling NATG From MEXC Amid Security Concerns

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Historic Records Set at 2026 CNO Monumental Marathon

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

2027 Toy of the Year Finalists Energize Play Market

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Invasive Procedures Don't Extend Life in Stable Heart Disease

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...